FOLD icon

Amicus Therapeutics
FOLD

Overview Fund Activity

211 hedge funds and large institutions have $3.27B invested in Amicus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
211
Holders Change
-5
Holders Change %
-2.31%
% of All Funds
3.57%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
26
Increased
67
Reduced
78
Closed
27
Calls
$11.9M
Puts
$3.45M
Net Calls
+$8.47M
Net Calls Change
+$7.48M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$288M
2
Citadel Advisors
2
Citadel Advisors
Florida
$40M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$23.1M
4
FC
4
Finepoint Capital
Massachusetts
$21.6M
5
State Street
5
State Street
Massachusetts
$149M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$118M
2
Jennison Associates
2
Jennison Associates
New York
$707K
3
IBT
3
International Biotechnology Trust
United Kingdom
$94.6K
4
WP
4
Woodline Partners
California
$0
5
PA
5
Perceptive Advisors
New York
$289M
Name Holding Trade Value Shares
Change 		Shares
Change %
EI
226
Ellevest Inc
New York
– -$4K -416 Closed
Bessemer Group
227
Bessemer Group
New Jersey
– -$3K -300 Closed
Kayne Anderson Rudnick Investment Management
228
Kayne Anderson Rudnick Investment Management
California
– -$2K -223 Closed
PNC Financial Services Group
229
PNC Financial Services Group
Pennsylvania
– -$1K -94 Closed
6 7 8 9
10